Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP651933.RAEdvp6FpUrb28x-golotPjiP0qXH4bIKa_IBREISbmEE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP651933.RAEdvp6FpUrb28x-golotPjiP0qXH4bIKa_IBREISbmEE130_assertion type Assertion NP651933.RAEdvp6FpUrb28x-golotPjiP0qXH4bIKa_IBREISbmEE130_head.
- NP651933.RAEdvp6FpUrb28x-golotPjiP0qXH4bIKa_IBREISbmEE130_assertion description "[Glucose over-utilization through the polyol pathway has been linked to tissue-based pathologies associated with diabetes complications, which make the development of a potent aldose reductase inhibitor an obvious and attractive strategy to prevent or delay the onset and progression of the complications.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP651933.RAEdvp6FpUrb28x-golotPjiP0qXH4bIKa_IBREISbmEE130_provenance.
- NP651933.RAEdvp6FpUrb28x-golotPjiP0qXH4bIKa_IBREISbmEE130_assertion evidence source_evidence_literature NP651933.RAEdvp6FpUrb28x-golotPjiP0qXH4bIKa_IBREISbmEE130_provenance.
- NP651933.RAEdvp6FpUrb28x-golotPjiP0qXH4bIKa_IBREISbmEE130_assertion SIO_000772 17497245 NP651933.RAEdvp6FpUrb28x-golotPjiP0qXH4bIKa_IBREISbmEE130_provenance.
- NP651933.RAEdvp6FpUrb28x-golotPjiP0qXH4bIKa_IBREISbmEE130_assertion wasDerivedFrom befree-20140225 NP651933.RAEdvp6FpUrb28x-golotPjiP0qXH4bIKa_IBREISbmEE130_provenance.
- NP651933.RAEdvp6FpUrb28x-golotPjiP0qXH4bIKa_IBREISbmEE130_assertion wasGeneratedBy ECO_0000203 NP651933.RAEdvp6FpUrb28x-golotPjiP0qXH4bIKa_IBREISbmEE130_provenance.